Business
Ondine Joins CAN Health Network
Ondine Joins CAN Health Network.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n12th May 2025\nONDINE BIOMEDICAL INC. (\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\nOndine Biomedical Joins CAN Health Network to Advance its Innovation in Infection Prevention Across Canada\nMembership provides strategic support, insights and connections as Ondine works to scale its infection prevention technology.\nOndine Biomedical Inc. (LON: OBI) is pleased to announce its membership with the CAN Health Network - a national initiative focused on accelerating the adoption of Canadian technology within the health care system. Through this membership, Ondine becomes part of a growing network of Canadian companies that are working to address some of the sector's most complex challenges with homegrown solutions.\nAs a member of the Network, Ondine will have access to strategic connections, tailored support, and valuable market insights to help advance the adoption of its innovative Steriwave® technology. This opportunity reflects Ondine's ongoing commitment to improving health outcomes and contributing to a stronger, more resilient Canadian health care system.\nThe CAN Health Network, a federally funded organization, is dedicated to scaling Canadian healthcare innovation companies by connecting them with healthcare operators nationwide. CAN Health facilitates the rapid commercialization and widespread adoption of Canadian-made solutions, enabling companies like Ondine to expand their reach and impact both domestically and in global markets.\nCarolyn Cross, CEO of Ondine Biomedical stated:\n\"Ondine Biomedical is proud to join the CAN Health Network. This membership provides us with valuable opportunities to collaborate with Canada's foremost healthcare innovators and further our goal of expanding access to Steriwave and delivering enhanced patient outcomes across the country.\"\nOndine's Steriwave nasal photodisinfection offers a transformative approach to infection prevention. This proprietary, light-activated antimicrobial rapidly eliminates pathogens, including multidrug-resistant strains, without contributing to the growing crisis of drug resistance.\nSteriwave has demonstrated significant reductions in post-surgical infections and impressive cost savings in both Canadian and UK hospitals. A 14-year study led by Professor John Street, Director of the Integrated Ambulatory Spine program at Vancouver General Hospi...